Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
about
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis.Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.Quality assurance of rifampicin-containing fixed-drug combinations in South Africa: dosing implications.Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment
P2860
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pharmacokinetic Evidence from ...... of Rifampin for Tuberculosis.
@en
type
label
Pharmacokinetic Evidence from ...... of Rifampin for Tuberculosis.
@en
prefLabel
Pharmacokinetic Evidence from ...... of Rifampin for Tuberculosis.
@en
P2093
P2860
P50
P356
P1476
Pharmacokinetic Evidence from ...... of Rifampin for Tuberculosis.
@en
P2093
C A Peloquin
C D Mitnick
D Vargas Vasquez
E Sanchez Garavito
M Milstein
P2860
P356
10.1128/AAC.00038-17
P407
P577
2017-05-30T00:00:00Z